Performance of early pregnancy HbA

Adult Diabetes, Gestational / epidemiology Europe Female Glycated Hemoglobin / analysis Humans Obesity / complications Pregnancy Pregnancy Outcome / epidemiology Prevalence
Diagnostic threshold Gestational diabetes mellitus Hemoglobin A(1c) Odds Ratio Pregnancy Pregnancy outcome

Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 24 04 2020
revised: 25 07 2020
accepted: 17 08 2020
pubmed: 24 8 2020
medline: 12 1 2021
entrez: 24 8 2020
Statut: ppublish

Résumé

To investigate the performance of early pregnancy HbA Post hoc analysis using data from the Vitamin D And Lifestyle Intervention for GDM prevention trials conducted across 9 European countries (2012-2014). Pregnant women (BMI ≥ 29 kg/m Among the 869 women tested, the prevalence of GDM was 25.9% before 20 weeks, with a further 8.6% at 24-28 weeks. The areas under the curves for HbA Early pregnancy HbA

Identifiants

DOI: 10.1016/j.diabres.2020.108378 PMID: 32828833
pubmed: 32828833
pii: S0168-8227(20)30631-8
doi: 10.1016/j.diabres.2020.108378
pii:
doi:

Substances chimiques

Glycated Hemoglobin A 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108378

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declared that there is no conflict of interest.

Auteurs

Jincy Immanuel (J)

Macarthur Clinical School, Western Sydney University, Sydney, Australia.

David Simmons (D)

Macarthur Clinical School, Western Sydney University, Sydney, Australia; Institute of Metabolic Science, Addenbrookes Hospital, Cambridge, England, UK. Electronic address: da.simmons@westernsydney.edu.au.

Gernot Desoye (G)

Department of Obstetrics and Gynecology, Medizinische Universitaet Graz, Graz, Austria.

Rosa Corcoy (R)

Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain; Institut de Recerca de ĺHospital de la Santa Creu i Sant Pau, Barcelona, Spain; CIBER Bioengineering, Biomaterials and Nanotechnology, Instituto de Salud Carlos III, Madrid, Spain.

Juan M Adelantado (JM)

Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.

Roland Devlieger (R)

KU Leuven Department of Development and Regeneration: Pregnancy, Fetus and Neonate, Belgium; Gynaecology and Obstetrics, University Hospitals Leuven, Belgium.

Annunziata Lapolla (A)

Universita Degli Studi di Padova, Padua, Italy.

Maria G Dalfra (MG)

Universita Degli Studi di Padova, Padua, Italy.

Alessandra Bertolotto (A)

Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.

Jürgen Harreiter (J)

Department of Medicine III, Division of Endocrinology, Gender Medicine Unit Medical University of Vienna, Vienna, Austria.

Ewa Wender-Ozegowska (E)

Department of Reproduction, Poznan University of Medical Sciences, Poland.

Agnieszka Zawiejska (A)

Department of Reproduction, Poznan University of Medical Sciences, Poland.

Fidelma P Dunne (FP)

National University of Ireland, Galway, Ireland.

Peter Damm (P)

Center for Pregnant Women with Diabetes, Departments of Endocrinology and Obstetrics, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Elisabeth R Mathiesen (ER)

Center for Pregnant Women with Diabetes, Departments of Endocrinology and Obstetrics, Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Dorte M Jensen (DM)

Steno Diabetes Center Odense, Odense University Hospital, Odense, Denmark; Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark; Department of Clinical Research, Faculty of Health Science, University of Southern Denmark, Odense, Denmark.

Lise Lotte T Andersen (LLT)

Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark; Department of Clinical Research, Faculty of Health Science, University of Southern Denmark, Odense, Denmark.

David J Hill (DJ)

Recherche en Santé Lawson SA, St. Gallen, Switzerland; Lawson Health Research Institute, London, Ontario, Canada.

Judith G M Jelsma (JGM)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.

Frank J Snoek (FJ)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Medical Psychology, Amsterdam, The Netherlands.

Hubert Scharnagl (H)

Medical University of Graz, Clinical Inst Medical and Chemical Laboratory Diagnostics, Graz, Austria.

Sander Galjaard (S)

KU Leuven Department of Development and Regeneration: Pregnancy, Fetus and Neonate, Belgium; Gynaecology and Obstetrics, University Hospitals Leuven, Belgium; Department of Obstetrics and Gynaecology, Division of Obstetrics and Prenatal Medicine, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands.

Alexandra Kautzky-Willer (A)

Department of Medicine III, Division of Endocrinology, Gender Medicine Unit Medical University of Vienna, Vienna, Austria; Gender Institute Gars am Kamp, Vienna, Austria.

Mireille N M VAN Poppel (MNM)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands; Institute of Sport Science, University of Graz, Graz, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Performance of early pregnancy HbA
questionsmedicales.fr › Maladies endocriniennes › Diabète › Diabète gestationnel › Performance of early pregnancy HbA
questionsmedicales.fr › Régions géographiques › Europe › Performance of early pregnancy HbA
questionsmedicales.fr › Facteurs biologiques › Toxines biologiques › Produits terminaux de glycation avancée › Protéines glyquées › Protéine glycosylée sérique › Hémoglobine glycosylée › Performance of early pregnancy HbA
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Performance of early pregnancy HbA
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Obésité › Performance of early pregnancy HbA
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Reproduction › Grossesse › Performance of early pregnancy HbA
questionsmedicales.fr › Phénomènes physiologiques des appareils urinaire et reproducteur › Phénomènes physiologiques de la reproduction › Reproduction › Grossesse › Issue de la grossesse › Performance of early pregnancy HbA
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Registre civil › Morbidité › Prévalence › Performance of early pregnancy HbA